Doximity, Inc. Class A (DOCS)

Doximity, Inc. (DOCS) stock price has experienced a significant decline over the past six months, hitting a new 52-week low of $43.21 on January 12, 2026. This downturn reflects a broader recalibration in the healthcare technology sector. The momentum began to stall in May 2025, following the release of the company's fiscal year 2025 results. Management's fiscal year 2026 revenue guidance fell short of Wall Street's expectations, leading to a 17% single-day stock drop. As of January 12, 2026, the stock was down 2.77% over the past 30 days and 15.95% over the past 12 months.

Doximity's revenue is primarily driven by a subscription model, with the vast majority coming from pharmaceutical companies, health systems, and medical recruiting firms. While the company has shown consistent revenue growth, there can be sequential quarterly declines, which is a known seasonality for DOCS. Demand for its telehealth and related services has continued to rise. Doximity's focus is shifting towards clinical AI products, aligning with growing physician demand for productivity-enhancing tools, which is expected to sustain and accelerate future growth.

Doximity, Inc. operates a digital platform for medical professionals in the United States, offering cloud-based tools for collaboration, medical updates, career management, documentation, and virtual patient visits. It serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. Key products and services include its newsfeed, telehealth tools, case collaboration features, and AI-powered tools like Doximity Scribe and DoxGPT.

Doximity, Inc. primarily operates and serves medical professionals within the United States. Its headquarters are located in San Francisco, California.

Doximity holds a dominant position as a professional network for U.S. medical professionals, with widespread adoption among physicians, nurse practitioners, and physician assistants. In August 2021, Doximity's news feed was reported to have vaccine misinformation, potentially impacting its reputation. In November 2023, Doximity launched DocDefender, a free service designed to remove physicians' personal information from public websites, which could positively contribute to its reputation. The company's strategic push into AI-driven workflow tools has been highlighted as a key factor in its market position and future outlook.

Doximity has a mixed ownership structure, with institutional shareholders holding approximately 65.56% to 90.29% of the company, insiders owning around 2.12% to 11.08%, and retail investors holding approximately 10.69% to 23.36%. Major institutional owners include BlackRock, Inc., Vanguard Group Inc, Fmr Llc, William Blair Investment Management, Llc, Capital World Investors, Clearbridge Investments, LLC, IJH - iShares Core S&P Mid-Cap ETF, State Street Corp, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, and Baillie Gifford & Co. Morgenthaler Venture Partners IX LP is noted as a significant individual shareholder.